SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-002524
Filing Date
2023-01-12
Accepted
2023-01-12 17:00:15
Documents
14
Period of Report
2023-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171610-8k_180lifesci.htm   iXBRL 8-K 32213
2 WARRANT AMENDMENT, DATED JANUARY 12, 2023, BY AND BETWEEN 180 LIFE SCIENCES CORP ea171610ex4-1_180lifesci.htm EX-4.1 6629
  Complete submission text file 0001213900-23-002524.txt   262659

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20230112.xsd EX-101.SCH 4004
4 XBRL DEFINITION FILE atnf-20230112_def.xml EX-101.DEF 26637
5 XBRL LABEL FILE atnf-20230112_lab.xml EX-101.LAB 36680
6 XBRL PRESENTATION FILE atnf-20230112_pre.xml EX-101.PRE 25261
8 EXTRACTED XBRL INSTANCE DOCUMENT ea171610-8k_180lifesci_htm.xml XML 5682
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 23526491
SIC: 2834 Pharmaceutical Preparations